Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 104

Results For "PAT"

6802 News Found

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology
Biotech | April 29, 2026

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use


Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation
R&D | April 29, 2026

Evonik and Higuchi launch “Open Pharma Lab” in Yokohama to accelerate oral drug Innovation

EUDRAGIT polymers remain a cornerstone technology in oral drug delivery


Illuminova ’26 showcases AI-driven future of medical education at SRM
Healthcare | April 29, 2026

Illuminova ’26 showcases AI-driven future of medical education at SRM

SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence


AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata
Drug Approval | April 29, 2026

AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata

After Phase 3 results show major hair regrowth gains


FDA okays AstraZeneca’s triple therapy Breztri for asthma
Medical Device | April 29, 2026

FDA okays AstraZeneca’s triple therapy Breztri for asthma

The aim is to simplify and strengthen long-term control of airway disease through triple therapy in one device


NADMED Limited appoints James Lee as CEO to drive global expansion
People | April 29, 2026

NADMED Limited appoints James Lee as CEO to drive global expansion

Former Novo Nordisk and Pharmanovia executive to lead next growth phase in NAD diagnostics and personalised health innovation


Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis
Healthcare | April 29, 2026

Laguna Diagnostics secures FDA breakthrough tag for mRNA test in psychiatric diagnosis

The company receives approval for blood-based test enabling objective differentiation of schizophrenia and bipolar disorder


Granules India  Q4FY26 revenue jumps 23% to Rs 14,706 million; FY26 revenue at Rs 53,656 million
News | April 29, 2026

Granules India Q4FY26 revenue jumps 23% to Rs 14,706 million; FY26 revenue at Rs 53,656 million

The figures highlight double-digit revenue growth, margin expansion, and continued momentum in complex generics and peptides CDMO platform


The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings
interviews | April 28, 2026

The next big opportunity lies in immune and rare disease white spaces: Venkat Nelabhotla, President & CEO, Vyome Holdings

With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints


Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care
Healthcare | April 28, 2026

Rheumatology Awareness Walkathon 2026 spotlights arthritis and autoimmune care

Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living